|
 |
 |
|
 |
Teva Announces Sale of Facility
Teva announced that it would sell its Sellersville, Pennsylvania facility to G&W Laboratories.

Advertisement:
Learn best practices of successful tableting, and tips and tricks for avoiding common manufacturing problems at Basics of Tablet Manufacturing and Troubleshooting, March 24-26, 2015. Reserve your spot for this hands-on course taught by Natoli Engineering's technical services and training experts that offers knowledge far beyond what can be learned in textbooks and webinars.
Learn More
|
J&J Loses First Jury Trial for Risperdal
Johnson & Johnson will pay $2.5 million to a plaintiff who developed gynecomastia after using Risperdal.

Advertisement:
15th Anniversary Celebration of CPhI China
Become an industry leader, Be part of Chinese pharma dream
The 15th CPhI China, together with the 10th P-MEC China, will be held at Shanghai New International Expo Center, on 24th June, 2015. After fifteen years' development, CPhI & P-MEC China has successfully become an important bridge between local companies and global pharmaceutical industry.
Learn More
|
FDA Postpones Hearing for Remicade Biosimilar
FDA announced that it would postpone a meeting that would be critical for the advancement of Celltrion's Remicade biosimilar in the US.

Advertisement:
Fundamentals of Spray-Dried Dispersion Technology
Live broadcast on: March 19th, 2015 at 11AM ET
Spray-dried dispersion technology is a proven approach to improve the dissolution rate and bioavailability of low solubility compounds, and helps to bring new medicines to market. Attend this webinar to learn the fundamentals of spray-dried dispersion formulation selection, process development, stability, scale-up, and performance considerations.
Register free:
www.pharmtech.com/spray
|
Superbug Antibiotic Lands FDA Approval
FDA approved Actavis' antibiotic Avycaz designed to combat drug-resistant bacteria.

Advertisement:
Applying Water Activity to Pharmaceutical Technology
Live broadcast on: March 25, 2015 at 11AM ET
Learn basics of water activity and the role it plays in the chemical stability, microbial content, and physical properties of pharmaceutical products. Hear experts discuss compendial and regulatory requirements for water-activity determination, and practical applications of water activity in marketed pharmaceuticals. Register free:
www.pharmtech.com/water
|
Celltrion Launches Remicade Biosimilar in European Markets
Remsima will now be available for patients in 12 additional countries in the European Union.

Novel Pharmaceutical Company, Turing, Announces Launch
Turing Pharmaceuticals announced the launch of its company, the acquisition of three assets from Retrophin, and a new senior management team.

Advertisement:
Enhancing Quality and Process Efficiency using Continuous Manufacturing Technology for Drug Substance and Drug Product
On Demand
Click here to Register free.
|
SGS Expands Biomarker Testing Capabilities at Poitiers Facility
SGS has invested in additional modules for its COBAS 6000 analysis system in a move to expand its biomarker analytical capabilities at its Poitiers facility in France.

Catalent Expands Clinical Packaging Capabilities in Europe
The company has increased capacity for cold storage and controlled drug substances handling at its European facilities.

|
|

©2015, UBM Advanstar
485F US Highway 1 South, Suite 210
Iselin, NJ 08830
|
|
|
|
 |
Advertisement:
Pharmaceutical Technology Solid Dosage Combo
Increase your knowledge of solid dosage technology and solid dose tablet manufacturing processes. These comprehensive pharmacology reference guides cover a variety of solid-dosage form principles such as oral solid-dosage forms, powders, mixing and blending, excipients, tableting, and coating. Drug delivery system manufacturing professionals can use the solid dosage manufacturing books to stay current with compressed tablet manufacturing processes, solid dosage processing equipment, tablet-pressing processes, and pharmaceutical industry trends in oral solid dosage manufacturing and solid dosage form development.
... Click here |
Contact Us
Click here to contact editorial.
Click here to contact sales.
|